Compliance » A Patented Method For Raising Drug Prices

A Patented Method For Raising Drug Prices


Dennis Crouch, writing in PatentlyO, describes a form of “paper infringement” used in conflicts between branded pharmaceuticals and their generic counterparts. It is a legal fiction that gives the branded drug maker the ability to immediately sue to keep the generic off the market. The lawsuits are considered a form of declaratory relief and no actual damages are available. As Crouch explains, this also means that these cases are not “Suits at common law” and so the right to a jury trial does not apply. The cases are ordinarily decided by bench trial, more often than not by one of the Delaware district court judges. Injunctive relief is notoriously hard to obtain in patent law, but this process will automatically delay any market approval by 30 months if the brand-patentee is the plaintiff.

Get our free daily newsletter

Subscribe for the latest news and business legal developments.

Read this next

Legal Ops Need to Assess Their Information Governance Programs

The AI Executive Order’s Impact on the Healthcare Industry

President Biden’s Executive Order on the Safe, Secure, and Trustworthy Development and […]

14 Proven Tactics to Elevate Your Law Firm's Webinars and Drive Results

Cybersecurity Agency Warns About Hacking Collective

The Cybersecurity and Infrastructure Security Agency and the FBI have issued a […]

Understanding Quantum Security Essential In Mitigating Risk Of Newest Cyber Threat

Data Privacy and Reputation Concerns About Adopting AI

Reputational damage was the greatest source of concern about AI, followed by […]

Scroll to Top